PIEZO1 and breast neoplasm: Both the in vivo and in vitro experiments validated the photothermal conversion efficiency of TiCN and witnessed the efficacy of Piezo1 specific agonist in enhancing the sensitivity of breast tumor to hyperthermia therapy under the 1,064 nm laser irradiation.